首页工具

登录

搜索结果

Search Results for " tnbc "

Targets Recommended: Others

57

抑制剂 & 化合物

4

天然产物

4

重组蛋白

如果没找到您满意的产品或者您对产品有其他要求，可以联系我们专业顾问为您提供针对性的合理建议。 QQ咨询网站留言咨询

Cat. No.	Product Name	Target	Signaling Pathways
T39815	anti-TNBC agent-1	Others	Others
	anti-TNBC agent-1 is a highly effective compound specifically designed to target and combat triple-negative breast cancer (TNBC). It demonstrates remarkable potency against various breast cancer cell types, with IC50 values spanning from 0.20 μM to 0.27 μM. The mechanism of action of anti-TNBC agent-1 involves inducing apoptosis in SUM-159 cells through the mitochondria pathway, as well as causing G1 phase arrest in these cells.
T79410	anti-TNBC agent-3	Others	Others
	Anti-TNBC agent-3 (compound 3g) 作为凋亡诱导剂，展现了抗增殖活性针对癌细胞。在三阴性乳腺癌(TNBC)异种移植模型上，该化合物有效地抑制了肿瘤生长及其转移。
T79699	anti-TNBC agent-2	Apoptosis	Apoptosis
	Anti-TNBC agent-2（3j）是一款针对三阴性乳腺癌（TNBC）的嘌呤衍生化合物。它能够引导MDA-MB-231细胞走向凋亡（apoptosis），阻碍其迁移和血管生成能力，并在TNBC异种移植模型中，抑制肿瘤生长与转移，同时下调Ki67和CD31蛋白的表达水平。Anti-TNBC agent-2主要用于三阴性乳腺癌的科研领域。
T9407	Rasarfin	Others; Ras	GPCR/G Protein; MAPK; Others
	Rasarfin 是Ras 和ARF6双抑制剂。
T10268	AGX51	Others	Others
	AGX51 是 DNA 结合蛋白抑制剂 (ID) 的拮抗剂。 AGX51 治疗导致泛 Id 降解、细胞周期停滞和细胞死亡。
T9468	FR054	Others	Others
	FR054 是一种己糖胺生物合成途径酶 PGM3 的抑制剂，具有明显的抗乳腺癌活性。它在不同的乳腺癌细胞中诱导细胞增殖和存活显著降低。
T8850	sbp-7455	Autophagy	Autophagy
	SBP-7455 是一种高亲和力，可口服的双重ULK1/ULK2自噬抑制剂，可有效抑制ULK1/2酶活性，可研究三阴性乳腺癌，在 ADP-Glo 分析中的IC50分别为 13 nM 和 476 nM。
T13780	MS1943	Apoptosis; Histone Methyltransferase	Apoptosis; Chromatin/Epigenetic
	MS1943 是一种具有口服生物活性的 EZH2选择性降解剂，IC50为 120 nM。它显著降低了许多三阴性乳腺癌和其他癌及非癌细胞系中的 EZH2蛋白水平，能有效阻止多个三阴性乳腺癌和其他癌细胞系的增殖。
T2436	GSK2801	Apoptosis; Epigenetic Reader Domain	Apoptosis; Chromatin/Epigenetic
	GSK2801 是一种有口服活性的和细胞活性的乙酰赖氨酸竞争性BAZ2A 和BAZ2B 溴结构域选择性抑制剂，Kd 值分别为 136 nM 和 257 nM。
T4325	COTI-2 COTI 2,COTI2	Apoptosis; p53	Apoptosis
	COTI-2是一种具有口服活性的低毒性抗癌药物，是 p53 突变体激活剂。它通过激活突变型 p53 和抑制PI3K/AKT/mTOR 途径发挥作用，通过 p53 依赖和非依赖机制在 HNSCC 中具有抗肿瘤活性。它诱导多种人肿瘤细胞凋亡，可将突变型 p53 转化为野生型构象。
T13044	Mevociclib SY-1365	CDK	Cell Cycle/Checkpoint
	Mevociclib (SY-1365) 是一种高效选择性 CDK7抑制剂，Ki 值为 17.4 nM。它具有抗血液肿瘤和侵袭性实体肿瘤作用，有抗增殖和凋亡活性。
T16961	Supinoxin RX-5902	Apoptosis; DNA/RNA Synthesis	Apoptosis; Cell Cycle/Checkpoint; DNA Damage/DNA Repair
	Supinoxin (RX-5902) 是磷酸化 p68 RNA 解旋酶的强效口服活性抑制剂，是一种抗肿瘤试剂。它与 Y593 磷酸化的 p68 相互作用并减弱 β-catenin 的核穿梭性。它诱导细胞凋亡并抑制 TNBC 癌细胞系的生长，IC50的范围为 10 nM 至 20 nM。
T6797	Telaglenastat CB 839,CB839,CB-839	transporter; Glutaminase; Autophagy	Autophagy; Metabolism; Proteases/Proteasome
	Telaglenastat (CB 839) 是一种谷氨酰胺酶 1 (GLS1) 抑制剂，具有选择性、可逆性和口服活性。Telaglenastat 具有抗肿瘤活性，可以诱导细胞自噬。
T9320	YK-3-237 B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid	Sirtuin	Chromatin/Epigenetic; DNA Damage/DNA Repair
	YK-3-237 (B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid) 是 SIRT1 激活剂，靶向突变体 p53。它抑制三阴性乳腺癌细胞的增殖。
T8934	(6R)-FR054 (3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐,FR054	Apoptosis; Others	Apoptosis; Others
	(6R)-FR054 是己糖胺生物合成途径酶 PGM3 的抑制剂，具有显著的抗乳腺癌作用。
T8808L	LYN-1604 dihydrochloride LYN-1604 2HCl（2216753-86-3 free base)	Apoptosis; Autophagy	Apoptosis; Autophagy
	LYN-1604 2HCl 是一种有效的 UNC-51 样激酶 1 激活剂，EC50值为 18.94 nM。LYN-1604 可研究三阴性乳腺癌。
T4123	LYN-1604 LYN1604	Apoptosis; Autophagy	Apoptosis; Autophagy
	LYN-1604 是一种新型 ULK1 激活剂，EC50值为 18.94 nM。它可诱导参与 ATF3、RAD21 和 caspase3 的细胞死亡，并伴有自噬和细胞凋亡，可研究三阴性乳腺癌。
T35528	TD52	Apoptosis; Phosphatase; Akt	Apoptosis; Cytoskeletal Signaling; Metabolism; PI3K/Akt/mTOR signaling
	TD52 是 PP2A (CIP2A) 癌性抑制剂的口服活性抑制剂。 TD52 是厄洛替尼衍生物，通过干扰 Elk1 与 CIP2A 启动子的结合间接降低了 CIP2A。
T5351L	PU-WS13 hydrobromide PU-WS13 hydrobromide (1454619-14-7 Free base)	GPR	Endocrinology/Hormones; GPCR/G Protein
	PU-WS13 hydrobromide 是一种 GRP94 抑制剂，具有抗炎活性，对小鼠 TNBC 肿瘤中的 M2 样巨噬细胞的增殖具有抑制作用。
T70353	JG-231	HSP	Cytoskeletal Signaling; Metabolism
	JG-231 是 JG-98 类似物，具有抗癌活性。JG-231 对三阴性乳腺癌 (TNBC) 的 MDA-MB-231 异植肿瘤模型具有抑制作用。JG-231 可抑制 Hsp70-BAG3 的相互作用。JG-231 对三阴性乳腺癌 (TNBC) 的 MDA-MB-231 异植肿瘤模型具有抑制作用。
T74178	Glembatumumab vedotin CR011-vcMMAE,CR 011 ADC,CDX-011	Microtubule Associated; Antibody-Drug Conjugates (ADCs)	Antibody-drug Conjugate/ADC Related; Cytoskeletal Signaling
	Glembatumumab vedotin (CDX-011) 是一种抗体活性小分子偶联物，Glembatumumab vedotin 具有强大的抗癌作用，可用于研究三阴性乳腺癌(TNBC)。
T77755	GPX4-IN-5	GPX	oxidation-reduction
	GPX4-IN-5 是一种小分子共价 GPX4 抑制剂（IC50: 0.12 μM），具有抗肿瘤活性。GPX4-IN-5 可促使铁死亡，可用于预防和治疗三阴性乳腺癌 (TNBC)。
T77759	GPX4-IN-6	GPX	oxidation-reduction
	GPX4-IN-6 是一种小分子共价 GPX4 抑制剂（IC50: 0.12 μM），具有抗肿瘤活性。GPX4-IN-6 可促使铁死亡，用于治疗=和预防三阴性乳腺癌 (TNBC)。
T68405L	KW-2450 Formate	Tyrosinase	Proteases/Proteasome
	KW-2450 Formate 是一种 IGF-1R/IR酪氨酸激酶抑制剂，具有抗肿瘤作用，通过抑制 Aurora A 和 B 激酶发挥作用。KW-2450 Formate 抑制 TNBC异种移植物的生长，诱导四倍体积累。
T14685	BMS-986158	Epigenetic Reader Domain	Chromatin/Epigenetic
	BMS-986158 是一种BET 抑制剂，在 MDA-MB231 三阴性乳腺癌细胞和 NCI-H211 小细胞肺癌细胞中，对 BET 的IC50分别为 5 和 6.6 nM。
T6224	Iniparib NSC-746045,IND-71677,3-硝基-4-碘苯甲酰胺,BSI-201	PARP; Influenza Virus	Chromatin/Epigenetic; DNA Damage/DNA Repair; Microbiology/Virology
	Iniparib (BSI-201) 是一种不可逆的 PARP1抑制剂，在三阴性乳腺 Y 中表现出效力。
T7296	THZ2 CDK7-IN-1	CDK	Cell Cycle/Checkpoint
	THZ2 (CDK7-IN-1) 是 THZ1 的类似物，是一种有效的选择性 CDK7 抑制剂，IC50值为 13.9 nM。它有治疗三阴性乳腺癌的潜力。
T8325	SR-4835	Apoptosis; CDK	Apoptosis; Cell Cycle/Checkpoint
	SR-4835 是一种 ATP 竞争性的 CDK12/CDK13高选择性抑制剂。它与破坏 DNA 的化学疗法和 PARP 抑制剂协同作用，并引起三阴性乳腺癌细胞凋亡。
T35528L	TD52 dihydrochloride TD52 dihydrochloride(1798328-24-1 Free base),TD52 2HCl	Others	Others
	TD52 dihydrochloride (TD52 2HCl), a derivative of Erlotinib, is a potent and orally active inhibitor of protein phosphatase 2A (CIP2A). It exhibits strong anti-cancer properties by regulating the CIP2A/PP2A/p-Akt signaling pathway, resulting in the induction of apoptosis in triple-negative breast cancer (TNBC) cells. Mechanistically, TD52 dihydrochloride disrupts the binding of Elk1 to the CIP2A promoter, effectively reducing CIP2A levels. Notably, TD52 dihydrochloride demonstrates powerful anti...
T20025	Imipramine HSDB 3100,Melipramine,HSDB3100,Dimipressin,HSDB-3100	Apoptosis	Apoptosis
	Imipramine (Dimipressin) 是一种具有口服活性的 Fascin1 抑制剂，具有抗抑郁和抗肿瘤活性。Imipramine 抑制 5-羟色胺转运体（IC50：32 nM），诱导细胞凋亡，诱导 U-87MG 胶质瘤细胞自噬。Imipramine 具有神经保护和免疫调节活性，抑制TNBC细胞的侵袭和迁移，可用于研究乳腺癌和癫痫。
T31539	DK-1-150 DK-1150,DK 1-150,DK1-150,DK 1 150	Others	Others
	DK-1-150 is an inducer of apoptotic cell death in TNBC cell lines without causing cytotoxicity in the normal mammary epithelial cell line.
T78787	PARP-1/2-IN-2	PARP	Chromatin/Epigenetic; DNA Damage/DNA Repair
	PARP-1/2-IN-2（Compound 12e）是一款抑制PARP1/2/CDK12的分子，IC50值分别为34、30和285 nM。该化合物阻碍DNA损伤修复过程，并能诱发细胞周期阻滞与细胞凋亡。此外，PARP-1/2-IN-2能够有效抑制三阴性乳腺癌（TNBC）细胞和异种移植瘤的增长。
T31540	DK-1-166 DK1-166,DK 1-166,DK-1166	Others	Others
	DK-1-166 is a inducer of apoptotic cell death in TNBC cell lines without causing cytotoxicity in the normal mammary epithelial cell line.
T74802	FAK-IN-9	Others	Others
	FAK-IN-9 (Compound 8f) 是一种有效的和具有口服活性的FAK 抑制剂，其IC50为 27.44 nM。FAK-IN-9 诱导三阴性乳腺癌 (TNBC) 细胞凋亡(apoptosis)。
T79405	PARP1-IN-15	PARP	Chromatin/Epigenetic; DNA Damage/DNA Repair
	PARP1-IN-15（Compound 6）是一款针对PARP1的抑制剂，能够抑制坦聚合酶(TNKS)并促进DNA双链断裂损伤。该化合物在诱导肿瘤细胞凋亡(apoptosis)方面具有显著作用，且在三阴性乳腺癌(TNBC)细胞及来源于TNBC患者的类器官中显示出抗癌活性，适用于探究BRCA1突变状态下的TNBC研究。
T74675	MS8815	PROTACs	PROTAC
	MS8815 是 zeste 同源物2(EZH2)PROTAC 降解剂，具有选择性。MS8815 对 EZH2有抑制活性，IC50值为 8.6 nM。MS8815 可用于三阴性乳腺癌 (TNBC) 研究。
T39687	LYN-1604 hydrochloride	Others	Others
	LYN-1604 hydrochloride, a powerful activator of UNC-51-like kinase 1 (ULK1) with an EC50 value of 18.94 nM, has significant implications in the study of triple-negative breast cancer (TNBC).
T72836	SHP2/CDK4-IN-1	Others	Others
	SHP2/CDK4-IN-1（化合物10）是一种针对SHP2和CDK4的口服双重抑制剂，具有IC50值分别为4.3和18.2 nM。该化合物能有效引起G0/G1期阻滞，抑制TNBC细胞的增殖，并在EMT6同源小鼠模型中展现出明显的抗肿瘤活性，适用于三阴性乳腺癌（TNBC）的研究。
T82758	CDK9-Cyclin T1 PPI-IN-1	CDK	Cell Cycle/Checkpoint
	CDK9-Cyclin T1 PPI-IN-1 (Compound B19) 是CDK9-Cyclin T1蛋白-蛋白相互作用的选择性抑制剂。该化合物能够有效抑制TNBC MDA-MB-231细胞系的细胞增殖(IC50: 0.044 μM)，诱导细胞凋亡，同时降低CDK9的转录活性并减少RNA Pol II CTD ser2的磷酸化，有效地抑制了4T1移植瘤模型小鼠中肿瘤的生长。
T13889	SLLN-15	Others	Others
	SLLN-15 是一个具有口服活性的、选择性的、有效的自噬 (autophagy) 增强剂。SLLN-15 可激活三阴乳腺癌细胞的自噬。
T80217	BT1718	MMP	Proteases/Proteasome
	BT1718是一种针对MT1-MMP的双功能抗癌肽，通过MT1-MMP靶向肿瘤来传递细胞毒性有效载荷Mertansine。作为一种多肽-毒素偶联物，其KD值为3 nM。MT1-MMP在多种晚期实体肿瘤如三阴性乳腺癌(TNBC)和非小细胞肺癌中呈现过表达。
T79369	ZMF-23	PAK	Cytoskeletal Signaling
	ZMF-23 是一种针对PAK1和HDAC6的双重抑制剂，能够抑制这两种酶控制的有氧糖酵解过程和细胞迁移。它促使TNF-α 介导的坏死性凋亡（necroptosis），并增强细胞凋亡（apoptosis）。ZMF-23 还可作为研究三阴性乳腺癌（TNBC）的工具，因其能够抑制Warburg效应及细胞迁移。
T74784	LL-K8-22	Others	Others
	LL-K8-22 是一款高效且具有选择性和持久性的 CDK8-cyclin C 双重降解剂，其DC50值分别为2.52 μM和2.64 μM。该化合物还能抑制STAT1Ser 727的磷酸化，并能抑制由E2F 和 MYC 驱动的致癌转录程序，适用于三阴性乳腺癌 (TNBC) 的研究。
T63991	BRD4/CK2-IN-1	Others	Others
	BRD4/CK2-IN-1 是高效的、口服具有活力的 BRD4/CK2 (含溴结构域蛋白 4/酪蛋白激酶 2) 双靶点抑制剂，能够作用于 BRD4 (IC50: 180 nM) 和 CK2 (IC50: 230 nM)。在三阴性乳腺癌 (TNBC) 中，BRD4/CK2-IN-1 能够诱导细胞凋亡和自噬相关的细胞死亡。BRD4/CK2-IN-1 表现出显著的抗癌效果，且没有明显毒性。
T74359	PP-C8	PROTACs	PROTAC
	PP-C8 是一种有效的选择性 PROTACCDK12-Cyclin K 降解剂。PP-C8 诱导 CDK12-Cyclin K 降解，对 CDK12 和 Cyclin K 的DC50分别为 416 和 412 nM。PP-C8 与PARP 抑制剂在三阴性乳腺癌 (TNBC) 中具有高效的协同抗增殖作用。
T61888	mTOR/HDAC6-IN-1	Others	Others
	mTOR/HDAC6-IN-1 是一种有效的组蛋白去乙酰酶 (HDAC6)和哺乳动物雷帕霉素 (mTOR) 的双重抑制剂，对于HDAC6 和 mTOR 的IC50值分别为56 nM 和133.7 nM。mTOR/HDAC6-IN-1 对细胞自噬 (autophagy)、细胞凋亡 (apoptosis)具有明显的诱导作用，对迁移具有抑制作用。mTOR/HDAC6-IN-1 在三阴性乳腺癌 (TNBC) 的研究中具有潜力
T61582	Anticancer agent 57	Others	Others
	Anticancer agent 57 (compound 14) demonstrates potent inhibition of MDA-MB-231, MDA-MB-468, and MCF-7 cell lines, with IC 50 values ranging from 6.43 to 8.00 μM. Additionally, this agent induces cell cycle arrest and promotes apoptosis. In vivo studies using nude mice xenografted with MADMB-231 cells have shown that Anticancer agent 57 effectively inhibits tumor growth. Consequently, Anticancer agent 57 can serve as a valuable tool for researching triple negative breast cancer (TNBC) [1].
T79776	ZZM-1220	Histone Methyltransferase	Chromatin/Epigenetic
	ZZM-1220是一种针对组蛋白赖氨酸甲基转移酶G9a/GLP的共价抑制剂，IC50值分别为458 nM和924 nM。该化合物能有效抑制H3K9me2在细胞中的作用，从而显著促进三阴性乳腺癌(TNBC)细胞的凋亡(apoptosis)，同时在G2/M期阻断细胞周期的进程。
T78753	Aurora Kinases-IN-4	Aurora Kinase	Cell Cycle/Checkpoint; Chromatin/Epigenetic
	Aurora Kinases-IN-4（Compound 11c）是共价ATP竞争型aurora kinaseA抑制剂，具有IC50为1.7 nM。该化合物对SJSA-1、MDA-MB-231、A549和HeLa细胞系的增殖抑制效果显著，其IC50分别为4.27、1.54、3.08和6.99 μM。Aurora Kinases-IN-4适用于三阴性乳腺癌（TNBC）的相关研究。
T79780	IHMT-EZH2-426	Histone Methyltransferase	Chromatin/Epigenetic
	IHMT-EZH2-426（compound 38）是一种针对EZH2野生型及其A687V和Y641F/Y641N/Y641S突变体高效的共价降解剂，其IC50值分别为1.3 nM、1.2 nM以及1.7-3.5 nM。该化合物通过下调H3K27me3和EZH2蛋白表达水平，显著抑制B细胞淋巴瘤和三阴性乳腺癌（TNBC）细胞系的增殖。

化合物

anti-TNBC agent-1

Cat.No: T39815

Target: Others

anti-TNBC agent-3

Cat.No: T79410

Target: Others

anti-TNBC agent-2

Cat.No: T79699

Target: Apoptosis

Cat.No: T9407

Target: Others, Ras

Cat.No: T10268

Target: Others

Cat.No: T9468

Target: Others

Cat.No: T8850

Target: Autophagy

Cat.No: T13780

Target: Apoptosis, Histone Methyltransferase

Cat.No: T2436

Target: Apoptosis, Epigenetic Reader Domain

Cat.No: T4325

Synonym: COTI 2,COTI2

Target: Apoptosis, p53

Cat.No: T13044

Synonym: SY-1365

Target: CDK

Cat.No: T16961

Synonym: RX-5902

Target: Apoptosis, DNA/RNA Synthesis

Cat.No: T6797

Synonym: CB 839,CB839,CB-839

Target: transporter, Glutaminase, Autophagy

Cat.No: T9320

Synonym: B-[2-Methoxy-5-[(1E)-3-oxo-3-(3,4,5-trimethoxyphenyl)-1-propen-1-yl]phenyl]boronic acid

Target: Sirtuin

Cat.No: T8934

Synonym: (3AR,7AR)-5-(乙酰氧基甲基)-2-甲基-5,6,7,7A-四氢-3AH-吡喃并[3,2-D]噁唑-6,7-叉基二醋酸盐,FR054

Target: Apoptosis, Others

LYN-1604 dihydrochloride

Cat.No: T8808L

Synonym: LYN-1604 2HCl（2216753-86-3 free base)

Target: Apoptosis, Autophagy

Cat.No: T4123

Synonym: LYN1604

Target: Apoptosis, Autophagy

Cat.No: T35528

Target: Apoptosis, Phosphatase, Akt

PU-WS13 hydrobromide

Cat.No: T5351L

Synonym: PU-WS13 hydrobromide (1454619-14-7 Free base)

Target: GPR

Cat.No: T70353

Target: HSP

Glembatumumab vedotin

Cat.No: T74178

Synonym: CR011-vcMMAE,CR 011 ADC,CDX-011

Target: Microtubule Associated, Antibody-Drug Conjugates (ADCs)

Cat.No: T77755

Target: GPX

Cat.No: T77759

Target: GPX

KW-2450 Formate

Cat.No: T68405L

Target: Tyrosinase

Cat.No: T14685

Target: Epigenetic Reader Domain

Cat.No: T6224

Synonym: NSC-746045,IND-71677,3-硝基-4-碘苯甲酰胺,BSI-201

Target: PARP, Influenza Virus

Cat.No: T7296

Synonym: CDK7-IN-1

Target: CDK

Cat.No: T8325

Target: Apoptosis, CDK

TD52 dihydrochloride

Cat.No: T35528L

Synonym: TD52 dihydrochloride(1798328-24-1 Free base),TD52 2HCl

Target: Others

Cat.No: T20025

Synonym: HSDB 3100,Melipramine,HSDB3100,Dimipressin,HSDB-3100

Target: Apoptosis

Cat.No: T31539

Synonym: DK-1150,DK 1-150,DK1-150,DK 1 150

Target: Others

Cat.No: T78787

Target: PARP

Cat.No: T31540

Synonym: DK1-166,DK 1-166,DK-1166

Target: Others

Cat.No: T74802

Target: Others

Cat.No: T79405

Target: PARP

Cat.No: T74675

Target: PROTACs

LYN-1604 hydrochloride

Cat.No: T39687

Target: Others

Cat.No: T72836

Target: Others

CDK9-Cyclin T1 PPI-IN-1

Cat.No: T82758

Target: CDK

Cat.No: T13889

Target: Others

Cat.No: T80217

Target: MMP

Cat.No: T79369

Target: PAK

Cat.No: T74784

Target: Others

Cat.No: T63991

Target: Others

Cat.No: T74359

Target: PROTACs

mTOR/HDAC6-IN-1

Cat.No: T61888

Target: Others

Anticancer agent 57

Cat.No: T61582

Target: Others

Cat.No: T79776

Target: Histone Methyltransferase

Aurora Kinases-IN-4

Cat.No: T78753

Target: Aurora Kinase

Cat.No: T79780

Target: Histone Methyltransferase

Cat. No.	Product Name	Target	Signaling Pathways
T7979	2-Hydroxychalcone 2-(2-Hydroxybenzal)Acetophenone,2-羟基查酮	Apoptosis; BCL; Others; NF-κB	Apoptosis; NF-κB; Others
	2-Hydroxychalcone (2-(2-Hydroxybenzal)Acetophenone) 是一种天然黄酮，可通过下调 Bcl-2 诱导凋亡，也可抑制NF-kB 的激活。它是抗氧化剂，抑制脂质过氧化，还可抑制三阴性乳腺癌细胞的侵袭。
T4S1383	Escin IA Aescin IA,Escin IA;Aescin IA,Escin IA	HIV Protease	Microbiology/Virology; Proteases/Proteasome
	Escin IA (Escin IA;Aescin IA);Aescin IA 是从马蹄中七叶树分离出的一种三萜皂苷，抑制HIV-1蛋白酶，IC50值为 35 μM。它具有抗 TNBC 转移活性，其作用机制涉及通过下调 LOXL2 表达抑制上皮-间质转化过程。
TN1493	Chrysosplenol D 猫眼草酚D	IL Receptor; NF-κB; JNK	Immunology/Inflammation; MAPK; NF-κB
	Chrysosplenol D 属于甲氧基黄酮类化合物，可诱导 ERK1/2 介导的三阴性人乳腺癌细胞凋亡。它还显示出抗炎和中等抗锥虫活性。
TN2691	2',3'-Dehydrosalannol	BCL; Akt; Caspase	Apoptosis; Cytoskeletal Signaling; PI3K/Akt/mTOR signaling; Proteases/Proteasome
	2',3'-Dehydrosalannol possesses antifeedant activity against Spodptera litura. It shows anticancer effects on triple-negative breast cancer(TNBC), it inhibits cathepsin-mediated pro-survival signaling which resulted in growth arrest of TNBC cells.

天然产物

2-Hydroxychalcone

Cat.No: T7979

Synonym: 2-(2-Hydroxybenzal)Acetophenone,2-羟基查酮

Target: Apoptosis, BCL, Others, NF-κB

Cat.No: T4S1383

Synonym: Aescin IA,Escin IA;Aescin IA,Escin IA

Target: HIV Protease

Chrysosplenol D

Cat.No: TN1493

Synonym: 猫眼草酚D

Target: IL Receptor, NF-κB, JNK

2',3'-Dehydrosalannol

Cat.No: TN2691

Target: BCL, Akt, Caspase

Species：

Expression System：

Tag：

Cat. No.	Product Name	Species	Expression System
TMPY-04203	RAB1B Protein, Human, Recombinant (hFc) RAB1B, member RAS oncogene family	Human	HEK293 Cells
	RAB1B, a member of the RAS oncogene family, was significantly down-regulated in highly metastatic breast cancer cells. Moreover, down-regulation of RAB1B was also found to promote the proliferation and migration of TNBC cells in vitro and in vivo. Mechanistically, loss of RAB1B resulted in elevated expression of TGF-beta receptor 1 (TbetaR1) through decreased degradation of ubiquitin, increased levels of phosphorylated SMAD3 and TGF-beta-induced epithelial-mesenchymal transition (EMT). Furthermo...
TMPK-00007	TFF1 Protein, Human, Recombinant (hFc) Polypeptide P1.A,Trefoil factor 1,Bcei,HP1.A,pNR-2,PS2,HPS2,...	Human	HEK293 Cells
	Breast cancer (BC) is the most common cancer in women and the second leading cause of their cancer death. Establishing an accurate BC prognosis is very difficult because of its heterogeneity. Elevated TFF1 levels in serum were associated with development of BC, TFF1 expression was upregulated in BC compared to the healthy breast tissue.That expression of TFF1 was related to ER status of BC and that expression of TFF1 was lower in TNBC than in non-TNBC. TFF1 Protein, Human, Recombinant (hFc) is e...
TMPK-00941	TFF1 Protein, Mouse, Recombinant (hFc) HP1.A,D21S21,TFF1,Polypeptide P1.A,PS2,BCEI,pNR-2,HPS2,Trefo...	Mouse	HEK293 Cells
	Breast cancer (BC) is the most common cancer in women and the second leading cause of their cancer death. Establishing an accurate BC prognosis is very difficult because of its heterogeneity. Elevated TFF1 levels in serum were associated with development of BC, TFF1 expression was upregulated in BC compared to the healthy breast tissue.That expression of TFF1 was related to ER status of BC and that expression of TFF1 was lower in TNBC than in non-TNBC. TFF1 Protein, Mouse, Recombinant (hFc) is e...
TMPY-04817	Syntenin Protein, Human, Recombinant (His) MDA-9,SYCL,TACIP18,syndecan binding protein (syntenin),ST1,M...	Human	E. coli
	Syntenin1/SDCBP (syndecan binding protein), also known as melanoma differentiation associated gene-9 (MDA-9), is a PDZ domain-containing molecule, which was initially identified as a key oncogene in melanoma. IL-6 promotes glioma cell proliferation and invasion by inducing SDCBP expression, which is mediated by JAK2/STAT3 signaling. SDCBP might be an important marker for identifying Triple negative breast cancer (TNBC) cases that are suitable for dasatinib therapy.

重组蛋白

RAB1B Protein, Human, Recombinant (hFc)

Cat.No: TMPY-04203

Species: Human

Expression System: HEK293 Cells

TFF1 Protein, Human, Recombinant (hFc)

Cat.No: TMPK-00007

Species: Human

Expression System: HEK293 Cells

TFF1 Protein, Mouse, Recombinant (hFc)

Cat.No: TMPK-00941

Species: Mouse

Expression System: HEK293 Cells

Syntenin Protein, Human, Recombinant (His)

Cat.No: TMPY-04817

Species: Human

Expression System: E. coli

我们的所有产品和服务仅用于科学研究，不能被用于人体，我们也不向个人提供产品和服务。

Copyright © 2015-2024 TargetMol Chemicals Inc. All rights reserved. 沪ICP备20019793号-4

沪公网安备 31010602006700号

沪公网安备 31010602006700号

TargetMol Loading

联系我们

电话：

400-820-0310

邮箱：

service@tsbiochem.com

QQ：

2881945090（终端用户）

2885109491（经销商）

经销：

终端：

地址：

上海市静安区江场三路238号8楼